NASDAQ:MBOT - Microbot Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.67 +0.01 (+1.52 %)
(As of 07/19/2018 08:00 AM ET)
Previous Close$0.69
Today's Range$0.67 - $0.69
52-Week Range$0.58 - $1.55
Volume125,800 shs
Average Volume139,330 shs
Market Capitalization$29.30 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.05
Microbot Medical logoMicrobot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Receive MBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MBOT
CUSIPN/A
Phone781-875-3605

Debt

Debt-to-Equity RatioN/A
Current Ratio21.04
Quick Ratio21.04

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$120,000.00
Price / Sales244.10
Cash FlowN/A
Price / CashN/A
Book Value$0.27 per share
Price / Book2.48

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-7,580,000.00
Net MarginsN/A
Return on Equity-49.03%
Return on Assets-46.53%

Miscellaneous

Employees7
Outstanding Shares43,720,000
Market Cap$29.30

The Truth About Cryptocurrencies

Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

When did Microbot Medical's stock split? How did Microbot Medical's stock split work?

Shares of Microbot Medical reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc (NASDAQ:MBOT) announced its quarterly earnings results on Tuesday, May, 15th. The biotechnology company reported ($0.03) EPS for the quarter, beating the Zacks' consensus estimate of ($0.04) by $0.01. View Microbot Medical's Earnings History.

When is Microbot Medical's next earnings date?

Microbot Medical is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Microbot Medical.

What price target have analysts set for MBOT?

1 equities research analysts have issued 1 year price objectives for Microbot Medical's stock. Their predictions range from $1.75 to $1.75. On average, they expect Microbot Medical's stock price to reach $1.75 in the next twelve months. This suggests a possible upside of 161.2% from the stock's current price. View Analyst Ratings for Microbot Medical.

What is the consensus analysts' recommendation for Microbot Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Microbot Medical's key competitors?

Who are Microbot Medical's key executives?

Microbot Medical's management team includes the folowing people:
  • Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 45)
  • Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 66)
  • Mr. Yoseph Bornstein, Co-Founder & Director (Age 59)
  • Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 49)
  • Mr. Yehezkel Himelfarb, COO, GM of Israeli operations & Director (Age 60)

Has Microbot Medical been receiving favorable news coverage?

Press coverage about MBOT stock has trended somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Microbot Medical earned a news sentiment score of 0.10 on Accern's scale. They also assigned press coverage about the biotechnology company an impact score of 45.96 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Microbot Medical?

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $0.67.

How big of a company is Microbot Medical?

Microbot Medical has a market capitalization of $29.30 million and generates $120,000.00 in revenue each year. Microbot Medical employs 7 workers across the globe.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]


MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  155 (Vote Underperform)
Total Votes:  380
MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.